Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: LifeVantage Corporation

Market Cap 77.97M 68.49M 63.11M 59.08M 111M 7.39B 113M 758M 293M 3.62B 293M 286M 12.59B P/E 2026 *
14.7x
P/E 2027 * 15.8x
Enterprise Value 64.42M 56.59M 52.14M 48.81M 91.46M 6.1B 93M 626M 242M 2.99B 242M 237M 10.41B EV / Sales 2026 *
0.35x
EV / Sales 2027 * 0.35x
Free-Float
83.58%
Yield 2026 *
-
Yield 2027 * -
1 day+0.40%
1 week+1.98%
Current month-21.47%
1 month-10.82%
3 months+42.73%
6 months-2.37%
Current year+0.32%
1 week 5.8
Extreme 5.8
6.7
1 month 5.52
Extreme 5.52
11.71
Current year 3.9
Extreme 3.9
11.71
1 year 3.9
Extreme 3.9
15
3 years 3.9
Extreme 3.9
27.38
5 years 3.04
Extreme 3.04
27.38
10 years 2.86
Extreme 2.86
27.38
Manager TitleAgeSince
Chief Executive Officer 74 2026-04-29
Director of Finance/CFO 53 2021-10-24
Chief Tech/Sci/R&D Officer - 2026-01-06
Director TitleAgeSince
Director/Board Member 74 2011-12-31
Director/Board Member 67 2017-01-31
Director/Board Member 68 2022-02-16
Date Insider Type Main position Quantity % Market Cap.
06-14Buy

Director

705 0.0056%
06-02Sell

Chief Executive Officer

-10,000 0.0793%
03-31Tax

General Counsel

1,446 0.0113%
Change 5-day change 1-year change 3-year change Capi.($)
+0.40%+1.98%-49.51%+47.85% 77.97M
+0.58%+1.26%+44.71%+148.69% 987B
+1.08%+3.71%+59.59%+48.43% 576B
-0.32%+6.86%+27.41%+75.18% 415B
+3.94%-1.30%+22.76%+15.66% 320B
+2.31%+3.99%+35.60%+24.07% 278B
+0.95%+3.80%+31.63%+41.25% 279B
+1.22%+9.23%-31.16%-41.97% 208B
+1.52%+3.32%+27.21%+57.08% 187B
+0.29%+0.73%+17.88%+65.06% 155B
Average +1.27%+1.59%+18.61%+48.13% 340.53B
Weighted average by Cap. +1.23%+0.73%+34.43%+70.82%

Financials

2026 *2027 *
Net sales 184M 162M 149M 140M 262M 17.45B 266M 1.79B 693M 8.56B 691M 677M 29.75B 178M 157M 144M 135M 253M 16.9B 258M 1.73B 671M 8.29B 670M 655M 28.81B
Net income 5.3M 4.66M 4.29M 4.02M 7.52M 502M 7.65M 51.51M 19.94M 246M 19.9M 19.47M 856M 4.9M 4.3M 3.97M 3.71M 6.96M 464M 7.07M 47.63M 18.44M 228M 18.39M 18M 792M
Net Debt -13.55M -11.9M -10.97M -10.27M -19.24M -1.28B -19.56M -132M -50.98M -630M -50.87M -49.77M -2.19B -15M -13.17M -12.14M -11.36M -21.29M -1.42B -21.65M -146M -56.42M -697M -56.29M -55.08M -2.42B
Logo LifeVantage Corporation
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
Employees
235
Date Price Change Volume
26-06-24 US$6.195 +0.24% 26,443
26-06-23 US$6.180 +1.64% 233,149
26-06-22 US$6.080 -5.15% 324,564
26-06-18 US$6.410 +5.78% 467,446
26-06-17 US$6.060 +0.33% 271,632
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.180USD
Average target price
7.000USD
Spread / Average Target
+13.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LFVN Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!